About Response Pharmaceuticals
Response Pharmaceuticals is a private company based in Falls Church, Virginia, incorporated in 2021 in Delaware. It has reported $11,886,635 raised in two offerings on Form D since March 2022. Its chief executive is Eric Keller.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 13, 2024 | Jun 28, 2024 | $3,898,385of $5.0M target | 51 | $76,439 | DebtRule 506(b) | Form D ↗ |
| Feb 8, 2022 | Mar 1, 2022amended Dec 5, 2022 | $7,988,250of $8.0M target | 127 | $62,900 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, two offerings | $11,886,635 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Response Pharmaceuticals's Form D filed Jun 28, 2024.
MB
Michael Berendt
Director
DO
Donald Olds
Director
EK
Earlier filings also listed Paul Sweetnam (executive officer, last listed Dec 2022).